Bluejay Diagnostics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bluejay Diagnostics, Inc. (BJDX) on June 2, 2026, covering events occurring on May 27, 2026. The Company is an emerging growth company incorporated in Delaware and trades on The Nasdaq Stock Market LLC. The filing primarily addresses the entry into a material definitive agreement to support the manufacturing of its Symphony™ platform.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual agreement rather than periodic financial performance data.
Material Changes and Agreements
On May 27, 2026, the Company entered into an Agreement and Statement of Work with Argonaut Manufacturing Services c/o Argonaut, Inc. ("Argonaut"). Key terms include:
- Scope of Services: Argonaut will provide planning, engineering, sourcing, supply chain management, formulation, filling, finishing, quality control testing, procurement of capital equipment, and product storage, delivery, and distribution.
- Product Focus: Services specifically relate to the Company's IL-6 testing products under the Symphony™ platform.
- Execution Mechanism: All services are to be performed pursuant to purchase orders issued by the Company to Argonaut from time to time.
Guidance, Outlook, and Risks
The filing includes a Regulation FD Disclosure referencing a press release issued on June 2, 2026, regarding this agreement. The text does not contain specific forward-looking guidance, management commentary on financial outlook, or a detailed discussion of risks and contingencies beyond the standard incorporation of the full agreement text. No unusual items were reported in this filing.
Investor Verification Checklist
- Review the full text of the Agreement and Statement of Work filed as Exhibit 10.1 to understand specific pricing, duration, and termination clauses.
- Verify the press release filed as Exhibit 99.1 for additional context on the strategic rationale for partnering with Argonaut.
- Monitor future purchase orders to assess the actual volume and financial impact of the manufacturing services.
- Confirm the status of the Symphony™ platform and IL-6 testing products in subsequent regulatory or operational updates.